Bobbi Bogaev, M.D., is the medical director, heart failure, at Abiomed, the maker of Impella. Impella is the only U.S. FDA-approved percutaneous heart pump technology indicated for patients with severe coronary artery disease requiring high-risk PCI. Prior to Abiomed, Dr. Bogaev was a practicing cardiologist and the chief of cardiology at Bon Secours Health System in Richmond, VA, director of Texas Heart Institute’s Advanced Heart Failure Outreach Program, and medical director of Texas Heart Institute’s Heart Transplant Program. She received her Doctor of Medicine (M.D.) from the University of Virginia and holds a Bachelor of Science in mechanical engineering from Virginia Polytechnic Institute and State University.
